Spravato® Treatment

Leading the Way in Advanced Mental Health Treatments

Certified Spravato® Treatment Center in Lebanon, TN

Roundtree  Mental Health Group believes in utilizing all evidence-based treatment options to better serve our clients, including newer medications and modalities of treatment. That’s why we’ve taken the steps necessary to become one of the first certified Spravato® treatment centers in the Lebanon area.

A groundbreaking treatment option for treatment-resistant depression

On March 5, 2019, the U.S. Food and Drug Administration (FDA) approved Spravato™ (esketamine) nasal spray. Spravato is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. Additionally, it’s approved for the quick resolution of major depression with suicidal ideation (MDSI). Spravato is the latest advancement in over a decade approved by the FDA to treat TRD.

Spravato® is brand name for esketamine produced by Janssen Pharmaceutical Company of Johnson & Johnson. Spravato® is only available in a nasal spray form, and only approved by the FDA for treating patients suffering from treatment-resistant depression (TRD) or major depression with suicidal thoughts.

Spravato® is FDA approved exclusively for adults suffering from Treatment Resistant Depression (TRD) or major depression with suicidal thoughts. Patients suffering from depression are typically considered treatment-resistant if they have not sufficiently responded to at least two different antidepressants of adequate dose and duration in the current depressive episode. To determine if Spravato® is right for you, contact our team at Athena Care to discuss your specific situation and treatment options.

Although Spravato® esketamine is administered as a nasal spray, people will not be permitted to purchase it for home use. To guard against abuse, patients will need to use Spravato® under medical supervision at a clinic or doctor’s office that has been certified by the maker of Spravato® as an authorized provider. Roundtree Mental Health Group is a certified authorized provider of Spravato®.

Spravato® is not for everyone.  Spravato® is only approved for adults suffering from Treatment Resistant Depression (TRD) or major depression with suicidal thoughts.  Your doctor will work with you to determine if you qualify for Spravato®. Contact us to discuss your specific situation, review the qualification requirements, and learn about treatment options.

Speak with a Provider

Contact us to learn more about Spravato®. For additional information about Spravato® from Janssen Pharmaceuticals, Inc., the maker of Spravato®, visit www.spravato.com.

Explore if Spravato® Is Right for You

Our team is here to help you understand your options and determine if Spravato® treatment could support your journey to wellness.